After Hiding My Undiagnosed Neurological Condition for Decades, I Finally Found Answers ...

An article shared by President Trump featured an upside-down pink triangle, crossed out by a red "no" symbol. Why LGBTQ+ and ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on discovery and development ...

The patent is based on preclinical trial results led by Professor Gal Yadid and his team at the Gonda Multidisciplinary Brain Research Center at Bar-Ilan University in Israel. These results followed ...

Shares of Clearmind are listed for trading on Nasdaq under the symbol "CMND" and the Frankfurt Stock Exchange ... SCI-110 for the treatment of Tourette Syndrome, for the treatment of Alzheimer's ...

MINGO JUNCTION — Hills Elementary School will celebrate neurodiversity with a series of activities planned during the week of March 17-21. Through the fourth-annual event, organizers are hoping to ...

What is lower crossed syndrome? If you’ve been told that you have lower crossed syndrome (LCS), you might wonder what this condition is, what causes it, and how it is treated. Lower crossed ...

With this focus, the Company is currently engaged in the following drug development programs based on THC and/or non-psychoactive CBD: SCI-110 for the treatment of Tourette Syndrome, for the treat ...

Thus, Gilles de la Tourette's disease is not the same as what today is labeled Tourette syndrome. Outside Charcot's circle, most physicians believed that multiple motor tics and coprolalia were a ...

During the double-blind withdrawal period, 41.9% of ecopipam-treated patients relapsed compared with 68.1% of placebo-treated patients. Topline data were announced from a phase 3 trial evaluating ...

Credit: Shutterstock / Studio Romantic Emalex Biosciences is eyeing approval for its Tourette syndrome therapy after it achieved its primary and secondary endpoints in a Phase III study. The US ...